​

Instil Bio Stock (NASDAQ:TIL)

ForecastOwnershipFinancialsChart
Instil Bio by TradingView

Previous Close

$7.36

52W Range

$5.67 - $25.89

50D Avg

$7.48

200D Avg

$8.38

Market Cap

$50.05M

Avg Vol (3M)

$11.91K

Beta

1.92

Div Yield

-

TIL Company Profile

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

17

IPO Date

Mar 19, 2021

Website

TIL Performance

TIL Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-52.91M$-73.54M$-159.17M
Net Income$-71.37M$-74.14M$-156.09M
EBITDA$-78.58M$-62.53M$-147.12M
Basic EPS$-10.70$-11.39$-24.00
Diluted EPS$-10.70$-11.39$-24.00

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
PLRXPliant Therapeutics, Inc.
IFRXInflaRx N.V.
ATOSAtossa Therapeutics, Inc.
ZNTLZentalis Pharmaceuticals, Inc.
TVGNTevogen Bio Holdings Inc.
ONCYOncolytics Biotech Inc.
STTKShattuck Labs, Inc.
WHWKWhitehawk Therapeutics Inc
MGNXMacroGenics, Inc.
SRZNSurrozen, Inc.